Nut consumption may decrease risk of colorectal, endometrial cancers

the ONA take:

According to a systematic review published in the journal Nutrition Reviews, researchers at the May Clinic in Rochester and the University of Minnesota in Minneapolis, Minnesota, have found that nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.

For the study, researchers analyzed data from 36 observation studies that included 30,708 patients. Results showed that nut consumption was associated with a decreased risk for colorectal, endometrial, and pancreatic cancer.

Researchers did not find an association between nut consumption and a reduced risk for other types of cancer or type 2 diabetes.

"Our study suggests that nut consumption may be associated with reduced risk of cancers, which may have practical implication. Aligning with the known beneficial effect of nuts on heart diseases, our study may imply that individuals interested in making better food choices to reduce the risk of cancer and heart disease can consider consuming nuts, after considering the caloric and fat contents of different types of nuts", said Lang Wu, principal investigator of the study.

Nut, peanut intake may lower risk of major causes of death
Nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.
A new systematic review and meta-analysis published in Nutrition Reviews on June 16 shows that nut consumption is, indeed, associated with a decreased risk of certain types of cancer, but not type 2 diabetes.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs